These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1190 related articles for article (PubMed ID: 34610047)
1. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study. Ge E; Li Y; Wu S; Candido E; Wei X PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death. Phelps M; Christensen DM; Gerds T; Fosbøl E; Torp-Pedersen C; Schou M; Køber L; Kragholm K; Andersson C; Biering-Sørensen T; Christensen HC; Andersen MP; Gislason G Eur Heart J Qual Care Clin Outcomes; 2021 Mar; 7(2):172-180. PubMed ID: 33107909 [TBL] [Abstract][Full Text] [Related]
3. Characteristics and outcomes of acute kidney injury in hospitalized COVID-19 patients: A multicenter study by the Turkish society of nephrology. Arikan H; Ozturk S; Tokgoz B; Dursun B; Seyahi N; Trabulus S; Islam M; Ayar Y; Gorgulu N; Karadag S; Gok M; Akcali E; Bora F; Aydın Z; Altun E; Ahbap E; Polat M; Soypacacı Z; Oguz EG; Koyuncu S; Colak H; Sahin İ; Dolarslan ME; Helvacı O; Kurultak I; Eren Z; Dheir H; Ogutmen MB; Taymez DG; Genek DG; Ozkurt S; Bakır EA; Yuksel E; Sahutoglu T; Oto OA; Boz G; Sengul E; Kara E; Tuglular S PLoS One; 2021; 16(8):e0256023. PubMed ID: 34375366 [TBL] [Abstract][Full Text] [Related]
4. The anatomy of COVID-19 comorbidity networks among hospitalized Korean patients. Shin EK; Choi HY; Hayes N Epidemiol Health; 2021; 43():e2021035. PubMed ID: 33971700 [TBL] [Abstract][Full Text] [Related]
5. Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis. Harrison SL; Fazio-Eynullayeva E; Lane DA; Underhill P; Lip GYH PLoS Med; 2020 Sep; 17(9):e1003321. PubMed ID: 32911500 [TBL] [Abstract][Full Text] [Related]
6. Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study. Abayomi A; Osibogun A; Kanma-Okafor O; Idris J; Bowale A; Wright O; Adebayo B; Balogun M; Ogboye S; Adeseun R; Abdus-Salam I; Mutiu B; Saka B; Lajide D; Yenyi S; Agbolagorite R; Onasanya O; Erinosho E; Obasanya J; Adejumo O; Adesola S; Oshodi Y; Akase IE; Ogunbiyi S; Omosun A; Erinoso F; Abdur-Razzaq H; Osa N; Akinroye K Glob Health Res Policy; 2021 Jul; 6(1):26. PubMed ID: 34325747 [TBL] [Abstract][Full Text] [Related]
7. Comorbidity-stratified estimates of 30-day mortality risk by age for unvaccinated men and women with COVID-19: a population-based cohort study. Abdel-Qadir H; Austin PC; Sivaswamy A; Chu A; Wijeysundera HC; Lee DS BMC Public Health; 2023 Mar; 23(1):482. PubMed ID: 36915068 [TBL] [Abstract][Full Text] [Related]
8. Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness. Ferastraoaru D; Hudes G; Jerschow E; Jariwala S; Karagic M; de Vos G; Rosenstreich D; Ramesh M J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1152-1162.e3. PubMed ID: 33495097 [TBL] [Abstract][Full Text] [Related]
9. Moderate to Severe Renal Insufficiency Is Associated With High Mortality After Hip and Knee Replacement. Jämsä P; Jämsen E; Huhtala H; Eskelinen A; Oksala N Clin Orthop Relat Res; 2018 Jun; 476(6):1284-1292. PubMed ID: 29601379 [TBL] [Abstract][Full Text] [Related]
10. Chronic diseases associated with increased likelihood of hospitalization and mortality in 68,913 COVID-19 confirmed cases in Spain: A population-based cohort study. Gimeno-Miguel A; Bliek-Bueno K; Poblador-Plou B; Carmona-Pírez J; Poncel-Falcó A; González-Rubio F; Ioakeim-Skoufa I; Pico-Soler V; Aza-Pascual-Salcedo M; Prados-Torres A; Gimeno-Feliu LA; PLoS One; 2021; 16(11):e0259822. PubMed ID: 34767594 [TBL] [Abstract][Full Text] [Related]
11. More severe comorbidities, advanced age, and incomplete vaccination increase the risk of COVID-19 mortality. Pradhevi L; Soegiarto G; Wulandari L; Lusida MA; Saefudin RP; Vincent A Narra J; 2024 Aug; 4(2):e949. PubMed ID: 39280314 [TBL] [Abstract][Full Text] [Related]
12. Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study. Aveyard P; Gao M; Lindson N; Hartmann-Boyce J; Watkinson P; Young D; Coupland CAC; Tan PS; Clift AK; Harrison D; Gould DW; Pavord ID; Hippisley-Cox J Lancet Respir Med; 2021 Aug; 9(8):909-923. PubMed ID: 33812494 [TBL] [Abstract][Full Text] [Related]
13. Influence of prior comorbidities and chronic medications use on the risk of COVID-19 in adults: a population-based cohort study in Tarragona, Spain. Vila-Córcoles A; Ochoa-Gondar O; Satué-Gracia EM; Torrente-Fraga C; Gomez-Bertomeu F; Vila-Rovira A; Hospital-Guardiola I; de Diego-Cabanes C; Bejarano-Romero F; Basora-Gallisà J BMJ Open; 2020 Dec; 10(12):e041577. PubMed ID: 33303459 [TBL] [Abstract][Full Text] [Related]
14. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK. Bloom CI; Drake TM; Docherty AB; Lipworth BJ; Johnston SL; Nguyen-Van-Tam JS; Carson G; Dunning J; Harrison EM; Baillie JK; Semple MG; Cullinan P; Openshaw PJM; Lancet Respir Med; 2021 Jul; 9(7):699-711. PubMed ID: 33676593 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis. Singh AK; Gillies CL; Singh R; Singh A; Chudasama Y; Coles B; Seidu S; Zaccardi F; Davies MJ; Khunti K Diabetes Obes Metab; 2020 Oct; 22(10):1915-1924. PubMed ID: 32573903 [TBL] [Abstract][Full Text] [Related]
16. Comparison of hospitalized patients with COVID-19 who did and did not live in residential care facilities in Montréal: a retrospective case series. Mah J; Lieu A; Palayew M; Alipour P; Kong LY; Song S; Palayew A; Tutt-Guérette MA; Yang SS; Wilchesky M; Lipes J; Azoulay L; Greenaway C CMAJ Open; 2021; 9(3):E718-E727. PubMed ID: 34257090 [TBL] [Abstract][Full Text] [Related]
17. Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative. Bennett TD; Moffitt RA; Hajagos JG; Amor B; Anand A; Bissell MM; Bradwell KR; Bremer C; Byrd JB; Denham A; DeWitt PE; Gabriel D; Garibaldi BT; Girvin AT; Guinney J; Hill EL; Hong SS; Jimenez H; Kavuluru R; Kostka K; Lehmann HP; Levitt E; Mallipattu SK; Manna A; McMurry JA; Morris M; Muschelli J; Neumann AJ; Palchuk MB; Pfaff ER; Qian Z; Qureshi N; Russell S; Spratt H; Walden A; Williams AE; Wooldridge JT; Yoo YJ; Zhang XT; Zhu RL; Austin CP; Saltz JH; Gersing KR; Haendel MA; Chute CG; JAMA Netw Open; 2021 Jul; 4(7):e2116901. PubMed ID: 34255046 [TBL] [Abstract][Full Text] [Related]
18. Risk factors for severe outcomes for COVID-19 patients hospitalised in Switzerland during the first pandemic wave, February to August 2020: prospective observational cohort study. Maximiano Sousa F; Roelens M; Fricker B; Thiabaud A; Iten A; Cusini A; Flury D; Buettcher M; Zukol F; Balmelli C; Zimmermann P; Troillet N; Vuichard-Gysin D; Schreiber PW; Bernhard-Stirnemann S; Tschudin-Sutter S; Nussbaumer-Ochsner Y; Sommerstein R; Gaudenz R; Marschall J; Senn L; Gardiol C; Keiser O; Schüpbach G; Wymann M; Vidondo B; Ch-Sur Study Group Swiss Med Wkly; 2021 Jul; 151():w20547. PubMed ID: 34324698 [TBL] [Abstract][Full Text] [Related]
19. Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study. Xu PP; Tian RH; Luo S; Zu ZY; Fan B; Wang XM; Xu K; Wang JT; Zhu J; Shi JC; Chen F; Wan B; Yan ZH; Wang RP; Chen W; Fan WH; Zhang C; Lu MJ; Sun ZY; Zhou CS; Zhang LN; Xia F; Qi L; Zhang W; Zhong J; Liu XX; Zhang QR; Lu GM; Zhang LJ Theranostics; 2020; 10(14):6372-6383. PubMed ID: 32483458 [No Abstract] [Full Text] [Related]
20. Machine learning to understand risks for severe COVID-19 outcomes: a retrospective cohort study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US health-care system. Wei Q; Mease PJ; Chiorean M; Iles-Shih L; Matos WF; Baumgartner A; Molani S; Hwang YM; Belhu B; Ralevski A; Hadlock J Lancet Digit Health; 2024 May; 6(5):e309-e322. PubMed ID: 38670740 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]